Netherlands' IMCD nine-month profit up 20%
Netherlands' IMCD nine-month profit up 20%
Overview
Netherlands specialty chemicals distributor's nine-month revenue rose 10% on a constant currency basis
Net result for the period increased 20% on a constant currency basis
Company cites sustained business momentum and 14% organic EBITA growth in Q3
Outlook
Company expects organic EBITA growth for the full yr
Result Drivers
BUSINESS MOMENTUM - Co said sustained business momentum and 14% organic EBITA growth in Q3 drove results
INITIATIVES - Co attributed performance to ongoing commercial, operational and digital excellence initiatives
Company press release: ID:nGNE6j6b7n
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
9M Net Income |
| EUR 211 mln |
|
9M EBITA |
| EUR 425 mln |
|
9M Free Cash Flow |
| EUR 317 mln |
|
9M Gross Profit |
| EUR 991 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy", 3 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the specialty chemicals peer group is "buy"
Wall Street's median 12-month price target for IMCD N.V. is €121.00, about 15.8% above its November 4 closing price of €104.50
The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 15 three months ago
Reuters Recommended Reads
Nov 3 - Switzerland's Clariant Q3 sales beat on higher prices, EBITDA misses on cost pressure
Nov 4 - Solvay Q3 revenue falls on soda ash weakness
Nov 3 - German chemical sector mood slips in October after two-month recovery, Ifo says
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)